Financial Data and Key Metrics Changes - Nareit defined FFO per share and unit was $0.97 for the quarter, with Core FFO at $1.16 per share and unit [19] - Net debt to adjusted EBITDA ratio improved to 6.2 times, a reduction of 0.7 times from the prior period [19] - Same-store cash NOI increased by 5.4% year-over-year and 2.9% sequentially [19] - The company will transition to a monthly dividend with an unchanged annual rate of $3 per share [19] - Initial 2026 Core FFO guidance is set at $4.30-$4.45 per share and unit, including anticipated headwinds of $0.36 [20] Business Line Data and Key Metrics Changes - The company is focusing on earnings growth from its existing portfolio while exploring new investment opportunities in senior housing [11][12] - The performance of the medical office sector has been consistent but modest, with rent growth being partially offset by capital and leasing costs [8] Market Data and Key Metrics Changes - The healthcare sector is expected to benefit from demographic tailwinds, particularly in senior housing, as the population aged 70 or older is projected to expand significantly [12] - The company has identified a bias towards higher prosperity markets in its asset demographic profile [9] Company Strategy and Development Direction - The company aims to build an organization that can deliver earnings growth in the upper quartile of the equity REIT universe, targeting a cash flow growth of 6% per year [11] - A strategic shift towards investing in senior housing has been initiated, with a focus on independent and assisted living, while avoiding skilled nursing facilities [26] - The company plans to capitalize on rising construction costs and demographic shifts to push rents in the coming years [10] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the challenges posed by a bear market in medical office due to interest rates and aims to adapt to a new normal of 4% 10-year Treasuries [6] - The company is optimistic about its future, believing it is well-positioned to grow through internal and external cash flows [21] Other Important Information - The company has no debt maturing before 2028, indicating a strong balance sheet position [11] - A recent investment in an active adult community in Minneapolis is expected to yield a double-digit unlevered IRR [17] Q&A Session Summary Question: Why is Chiron positioned to execute in seniors housing better than peers? - Management believes that delivering value and having a strong balance sheet with $100 million of EBITDA will help differentiate the company [24][25] Question: What is the focus in seniors housing? - The focus will be on independent and assisted living, with some memory care, while avoiding skilled nursing [26] Question: What yield targets are expected from the $250 million of potential asset sales? - Management is looking for a joint venture in the inpatient rehab space and expects to announce an LOI for a medical office sale in the next 60 days [28][29] Question: What is the status of the White Rock bankruptcy? - The operator is current on payments, and management is supportive of their efforts to succeed [31][32] Question: When did the strategy shift discussions begin? - Discussions started in August, with a multi-month evaluation process leading to a strategy laid out in December [36] Question: How will the company manage the transition to senior housing? - Management acknowledges the operating intensity of senior housing and plans to choose partners carefully to mitigate risks [42][43] Question: How many operators will the company work with in senior housing? - The company aims to work with a few regional operators with good track records and newer assets [50]

Financial Data and Key Metrics Changes - The NAREIT defined FFO per share and unit was $0.97 for the quarter, while Core FFO was $1.16 per share and unit [16] - Net debt to adjusted EBITDAre was 6.2 times for the quarter, a reduction of 0.7 times from the prior period [16] - Same-store cash NOI increased by 5.4% year-over-year and 2.9% sequentially [16] - The company will transition to a monthly dividend with an unchanged annual rate of $3 per share [16] - Initial 2026 Core FFO guidance is set at $4.30-$4.45 per share and unit, including anticipated headwinds of $0.36 [16] Business Line Data and Key Metrics Changes - The company is focusing on enhancing earnings growth from its existing portfolio while exploring new opportunities in senior housing [10][11] - The performance of the medical office sector has been consistent but modest, with rent growth being partially offset by capital and leasing costs [7][9] Market Data and Key Metrics Changes - The medical office market has been in a bear market primarily due to interest rates rather than asset performance [5][6] - The company has identified a demographic bias towards higher prosperity markets within its portfolio [9] Company Strategy and Development Direction - The company aims to build an organization that can deliver earnings growth in the upper quartile of the equity REIT universe, targeting a cash flow growth of 6% per year [10] - There is a strategic shift towards investing in senior housing, driven by demographic trends and constrained supply [11][12] - The company plans to focus on independent and assisted living, avoiding skilled nursing facilities [22] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the challenges posed by rising interest rates and aims to adapt to a new normal of 4% 10-year Treasuries [6] - The company believes in the economic and demographic tailwinds benefiting its existing portfolio and the broader healthcare real estate sector [10][11] - Management is optimistic about the future, emphasizing a commitment to delivering value and growth [10][11] Other Important Information - The company has no debt maturing before 2028, improving its balance sheet significantly [10] - A recent sale of an early vintage medical office for $10 million was executed to reduce execution risk and stabilize capital [14] Q&A Session Summary Question: Why does the company believe it can outperform peers in seniors housing? - Management believes that delivering value and having a strong balance sheet will help the company compete effectively in the seniors housing market [20][21] Question: What types of senior housing will the company focus on? - The focus will be on independent and assisted living, with some memory care, while avoiding skilled nursing [22] Question: What are the yield targets for the $250 million in potential asset sales? - Management indicated that they cannot force sales and are looking for favorable conditions to recycle capital [23][24] Question: What is the status of the White Rock bankruptcy and its impact? - The operator is current on payments, and management is supportive of their efforts to stabilize [26][27] Question: When did the strategy shift discussions begin? - Discussions started in August, with a multi-month evaluation process leading to a strategy laid out in December [31] Question: How will the company manage the transition to senior housing? - Management acknowledges the operational intensity of senior housing and plans to choose partners carefully to mitigate risks [39]

LISTED NYSE CHCT Investor Presentation February 2026 [TBU] Investor Presentation November 2020 At a Glance Community Healthcare Trust, Inc. NYSE: CHCT Market Data (as of December 31, 2025) Closing Price: $16.42 52 Week Range: $20.87 / $13.23 Market Cap: $467.5 million Enterprise Value: $996.4 million less % of Annualized Rent more 42nd Consecutive Quarter of Dividend Growth 198 Properties 323 Tenants 36 States Investor Presentation – February 2026 2 R: 0 G: 51 B: 160 R: 100 G: 100 B: 100 R: 0 G: 93 B: 170 R ...

Core Insights - Neo Ivy Capital Management has initiated a new position in American Healthcare REIT by purchasing 136,925 shares valued at approximately $6.44 million [2][8] - American Healthcare REIT has demonstrated strong financial performance, with a 16.4% same-store NOI growth in the third quarter, driven by significant increases in senior housing and integrated senior health campuses [7][10] - The company's stock price has increased by 93.3% over the past year, outperforming the S&P 500 with a one-year alpha of 80.37 percentage points [8] Company Overview - American Healthcare REIT operates a diversified portfolio of healthcare properties, including medical office buildings, senior housing communities, and skilled nursing facilities across the U.S. and U.K. [6][9] - The company has a market capitalization of $9.65 billion and reported a revenue of $2.20 billion for the trailing twelve months [4] - The dividend yield stands at 1.92%, indicating a return to shareholders [4] Financial Performance - GAAP net income attributable to controlling interest was reported at $55.9 million, equating to $0.33 per diluted share, while normalized FFO was $0.44 per share [10] - Management has raised full-year NFFO guidance to a range of $1.69 to $1.72, with expectations for same-store NOI growth reaching as high as 15% [10] Investment Implications - The new position by Neo Ivy Capital Management represents 1.02% of its reportable assets, indicating a strategic allocation to tap into healthcare real estate momentum [8][11] - The investment thesis for long-term investors is based on sustained occupancy rates above 90% in senior housing and disciplined capital allocation [11]

Core Viewpoint - Ventas, Inc. is positioned as a leading entity in the healthcare real estate sector, with a strong portfolio and positive growth outlook supported by strategic investments and favorable market conditions [1][2][3]. Group 1: Company Overview - Ventas, Inc. operates in the healthcare real estate sector, focusing on senior housing, medical office buildings, and research facilities [1]. - The company has a market capitalization of approximately $34.8 billion and a trading volume of 2,630,940 shares on the NYSE, indicating its significance in the healthcare REIT sector [5]. Group 2: Financial Performance - Ventas has a solid balance sheet and improved leverage, showcasing strong financial health and liquidity [3][6]. - The Zacks Consensus Estimate for Ventas' 2025 funds from operations (FFO) per share is projected to be $2.48, reflecting positive analyst sentiment [3]. Group 3: Growth Potential - The company’s strategic investments in its research portfolio and expansion of operations are driving portfolio growth and enhancing same-store cash net operating income (NOI) [4][6]. - Jefferies has set a price target of $93 for Ventas, suggesting a potential price increase of approximately 18.17% from its current price of $78.7, supported by the company's strong healthcare real estate portfolio [2][6]. Group 4: Market Position - Ventas' stock has seen an 11.9% rise over the past three months, contrasting with a 1.5% decline in the industry, indicating investor confidence in the company's performance [3][4]. - The company's diverse assets are well-positioned to benefit from rising healthcare spending and an aging population, enhancing its attractiveness to investors [2].